{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:24:49Z","timestamp":1791267889240,"version":"4.1.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10,23]]},"DOI":"10.1097\/qad.0b013e328358d4d7","type":"journal-article","created":{"date-parts":[[2012,8,8]],"date-time":"2012-08-08T16:37:04Z","timestamp":1344443824000},"page":"2053-2058","source":"Crossref","is-referenced-by-count":26,"title":["Reduced diastolic function and left ventricular mass in HIV-negative preadolescent children exposed to antiretroviral therapy in utero"],"prefix":"10.1097","volume":"26","author":[{"given":"W. Todd","family":"Cade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Waggoner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Hubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa J.","family":"Krauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Turner","family":"Overton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210130","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1161\/01.CIR.97.13.1246","article-title":"Left ventricular structure and function in children infected with human immunodeficiency virus: the prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group.","volume":"97","author":"Lipshultz","year":"1998","journal-title":"Circulation"},{"key":"R2-7-20210130","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/S0735-1097(03)00256-0","article-title":"Predictors of cardiac morbidity and related mortality in children with acquired immunodeficiency syndrome.","volume":"41","author":"Al-Attar","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R3-7-20210130","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/01.CIR.102.13.1542","article-title":"Cardiac dysfunction and mortality in HIV-infected children: The Prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group.","volume":"102","author":"Lipshultz","year":"2000","journal-title":"Circulation"},{"key":"R4-7-20210130","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0140-6736(02)09607-1","article-title":"Cardiovascular status of infants and children of women infected with HIV-1 (P(2)C(2) HIV): a cohort study.","volume":"360","author":"Lipshultz","year":"2002","journal-title":"Lancet"},{"key":"R5-7-20210130","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jacc.2010.08.620","article-title":"Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study).","volume":"57","author":"Lipshultz","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R6-7-20210130","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1385\/CT:4:3:271","article-title":"Cardiovascular effects of HAART in infants and children of HIV-infected mothers.","volume":"4","author":"Zareba","year":"2004","journal-title":"Cardiovasc Toxicol"},{"key":"R7-7-20210130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jcmg.2008.08.004","article-title":"Development of an echocardiographic risk-stratification index to predict heart failure in patients with stable coronary artery disease: the Heart and Soul study.","volume":"2","author":"Stevens","year":"2009","journal-title":"JACC Cardiovasc Imaging"},{"key":"R8-7-20210130","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ahj.2004.04.019","article-title":"Effects of diabetes mellitus and ischemic heart disease on the progression from asymptomatic left ventricular dysfunction to symptomatic heart failure: a retrospective analysis from the Studies of Left Ventricular Dysfunction (SOLVD) Prevention trial.","volume":"148","author":"Das","year":"2004","journal-title":"Am Heart J"},{"key":"R9-7-20210130","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1067\/mpd.2002.126301","article-title":"Incidence of cardiac abnormalities in children with human immunodeficiency virus infection: the prospective P2C2 HIV study.","volume":"141","author":"Starc","year":"2002","journal-title":"J Pediatr"},{"key":"R10-7-20210130","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1136\/hrt.2003.020966","article-title":"Echocardiographic predictors of adverse clinical events in children with dilated cardiomyopathy: a prospective clinical study.","volume":"90","author":"McMahon","year":"2004","journal-title":"Heart"},{"key":"R11-7-20210130","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","article-title":"Recommendations for chamber quantification: a report from the American Society of Echocardiographys Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.","volume":"18","author":"Lang","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"key":"R12-7-20210130","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.echo.2003.12.005","article-title":"Impact of cardiac growth on Doppler tissue imaging velocities: a study in healthy children.","volume":"17","author":"Eidem","year":"2004","journal-title":"J Am Soc Echocardiogr"},{"key":"R13-7-20210130","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.echo.2008.11.023","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography.","volume":"22","author":"Nagueh","year":"2009","journal-title":"J Am Soc Echocardiogr"},{"key":"R15-7-20210130","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0735-1097(97)88335-0","article-title":"Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function.","volume":"30","author":"Sohn","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"R16-7-20210130","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/cid\/ciq066","article-title":"High prevalence of echocardiographic abnormalities among HIV-infected persons in the era of highly active antiretroviral therapy.","volume":"52","author":"Mondy","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R17-7-20210130","first-page":"176","article-title":"Echocardiographic findings and abnormalities in HIV-infected patients: results from a large, prospective, multicenter HIV-heart study.","volume":"1","author":"Reinsch","year":"2011","journal-title":"Am J Cardiovasc Dis"},{"key":"R18-7-20210130","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1161\/CIRCHEARTFAILURE.109.854943","article-title":"Impact of HIV infection on diastolic function and left ventricular mass.","volume":"3","author":"Hsue","year":"2010","journal-title":"Circ Heart Fail"},{"key":"R19-7-20210130","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.amjcard.2007.11.073","article-title":"Subclinical cardiac abnormalities in human immunodeficiency virus-infected men receiving antiretroviral therapy.","volume":"101","author":"Schuster","year":"2008","journal-title":"Am J Cardiol"},{"key":"R20-7-20210130","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4330\/wjc.v2.i4.98","article-title":"Impaired diastolic function in naive untreated human immunodeficiency virus infected patients.","volume":"2","author":"Oliviero","year":"2010","journal-title":"World J Cardiol"},{"key":"R21-7-20210130","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/QAD.0b013e3283518f01","article-title":"Diastolic dysfunction is associated with myocardial viral load in simian immunodeficiency virus-infected macaques.","volume":"26","author":"Kelly","year":"2012","journal-title":"AIDS"},{"key":"R22-7-20210130","first-page":"158","article-title":"Left ventricular dysfunction is associated with CD4 lymphocyte count rather than opportunistic infection in human immunodeficiency virus infection.","volume":"102","author":"Chang","year":"2003","journal-title":"J Formos Med Assoc"},{"key":"R23-7-20210130","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/hrt.80.2.184","article-title":"Assessment of ventricular diastolic function in AIDS patients from Congo: a Doppler echocardiographic study.","volume":"80","author":"Longo-Mbenza","year":"1998","journal-title":"Heart"},{"key":"R24-7-20210130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1475-2840-10-111","article-title":"Effects of human immunodeficiency virus and metabolic complications on myocardial nutrient metabolism, blood flow, and oxygen consumption: a cross-sectional analysis.","volume":"10","author":"Cade","year":"2011","journal-title":"Cardiovasc Diabetol"},{"key":"R25-7-20210130","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/bmj.311.6998.171","article-title":"Fetal origins of coronary heart disease.","volume":"311","author":"Barker","year":"1995","journal-title":"BMJ"},{"key":"R26-7-20210130","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00126334-200207010-00006","article-title":"Use of HIV protease inhibitors is associated with left ventricular morphologic changes and diastolic dysfunction.","volume":"30","author":"Meng","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R27-7-20210130","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1056\/NEJM200009143431102","article-title":"Absence of cardiac toxicity of zidovudine in infants. Pediatric pulmonary and cardiac complications of vertically transmitted HIV infection study group.","volume":"343","author":"Lipshultz","year":"2000","journal-title":"N Engl J Med"},{"key":"R28-7-20210130","first-page":"91","article-title":"Molecular mechanisms of heart muscle disease.","volume":"154","author":"Lewis","year":"1991","journal-title":"West J Med"},{"key":"R29-7-20210130","first-page":"228","article-title":"Mitochondrial ultrastructural and molecular changes induced by zidovudine in rat hearts.","volume":"65","author":"Lewis","year":"1991","journal-title":"Lab Invest"},{"key":"R30-7-20210130","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1749-6632.2000.tb05496.x","article-title":"Fetal patas monkeys sustain mitochondrial toxicity as a result of in utero zidovudine exposure.","volume":"918","author":"Gerschenson","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"R31-7-20210130","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/0140-6736(91)91294-5","article-title":"Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy.","volume":"337","author":"Arnaudo","year":"1991","journal-title":"Lancet"},{"key":"R32-7-20210130","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jacc.2009.03.037","article-title":"The pathophysiology of heart failure with normal ejection fraction: exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist, and longitudinal motion.","volume":"54","author":"Tan","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R33-7-20210130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s12012-010-9061-3","article-title":"In utero exposure of female CD-1 Mice to AZT andor 3TC: I. Persistence of microscopic lesions in cardiac tissue.","volume":"10","author":"Torres","year":"2010","journal-title":"Cardiovasc Toxicol"},{"key":"R34-7-20210130","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/toxsci\/kfh208","article-title":"Mitochondrial damage revealed by morphometric and semiquantitative analysis of mouse pup cardiomyocytes following in utero and postnatal exposure to zidovudine and lamivudine.","volume":"81","author":"Bishop","year":"2004","journal-title":"Toxicol Sci"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002030-201210230-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:17:25Z","timestamp":1618039045000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201210230-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,23]]},"references-count":33,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e328358d4d7","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10,23]]}}}